Paper47148
Activation of the properdin pathway of complement in patients with gram-negative bacteremia.
Fearon DT and 3 others. N Engl J Med, 1975. Cited by 232 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Activation of the properdin pathway of complement in patients with gram-negative bacteremia. Papers, record 47148. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/47148
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activation of the properdin pathway of complement in patients with gram-negative bacteremia.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Complement System Proteins | Major topic |
| Properdin | Major topic |
| Sepsis | Major topic |
| Bacteriolysis | |
| Calcium | |
| Chemotaxis | |
| Histamine Release | |
| Humans | |
| Magnesium | |
| Neutrophils | |
| Protein Binding | |
| Shock, Septic |
Source PubMed
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 232 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,374,177 | Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness. | Am J Respir Crit Care Med | 2020 | https://conductscience.org/library/papers/32374177 | PubMed |
| 10,049,276 | Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10049276 | PubMed |
| 8,991,632 | Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. | Clin Diagn Lab Immunol | 1996 | https://conductscience.org/library/papers/8991632 | PubMed |
| 8,294,868 | The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. | J Exp Med | 1994 | https://conductscience.org/library/papers/8294868 | PubMed |
| 8,053,997 | C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. | Intensive Care Med | 1993 | https://conductscience.org/library/papers/8053997 | PubMed |
| 7,927,720 | Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor B. | Infect Immun | 1994 | https://conductscience.org/library/papers/7927720 | PubMed |
| 7,890,390 | Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1. | Infect Immun | 1995 | https://conductscience.org/library/papers/7890390 | PubMed |
| 7,400,321 | Role of complement activation in a model of adult respiratory distress syndrome. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7400321 | PubMed |
| 7,365,108 | Circulating immune complexes in patients with gram negative septic shock. | Intensive Care Med | 1980 | https://conductscience.org/library/papers/7365108 | PubMed |
| 7,298,850 | Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7298850 | PubMed |
| 7,260,760 | Fulminant gonococcemia after splenectomy. | Can Med Assoc J | 1980 | https://conductscience.org/library/papers/7260760 | PubMed |
| 7,188,198 | Septic shock--an update. | Indian J Pediatr | 1982 | https://conductscience.org/library/papers/7188198 | PubMed |
| 7,174,787 | Alternative complement pathway activation increases mortality in a model of burn injury in mice. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7174787 | PubMed |
| 7,095,560 | Endotoxaemia and complement activation in acute pancreatitis in man. | Gut | 1982 | https://conductscience.org/library/papers/7095560 | PubMed |
| 7,024,132 | Pulmonary opsonins in Klebsiella pneumoniae pneumonia in rats. | Infect Immun | 1981 | https://conductscience.org/library/papers/7024132 | PubMed |
| 7,012,215 | Immunological aspects to severe bacterial sepsis. | Intensive Care Med | 1981 | https://conductscience.org/library/papers/7012215 | PubMed |
| 6,969,058 | C3, factor B, alpha-1-antitrypsin in neonatal septicaemia with sclerema. | Arch Dis Child | 1980 | https://conductscience.org/library/papers/6969058 | PubMed |
| 6,908,546 | Demonstration of a local exhaustion of complement components and of an enzymatic degradation of immunoglobulins in pleural empyema: a possible factor favouring the persistence of local bacterial infections. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6908546 | PubMed |
| 6,904,257 | Complement activation in Staphylococcus aureus bacteraemia. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6904257 | PubMed |
| 6,859,992 | Preferential activation and depletion of the alternative complement pathway by burn injury. | Ann Surg | 1983 | https://conductscience.org/library/papers/6859992 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFP | 5,199 | PubTator's text mining | https://conductscience.org/library/genes/5199 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/47148
GET https://conductscience.org/api/papers/v1/47148/cited_by?page=2